Virtual Event
Advances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of our participants to cover a broad range of policy, research, and venture topics. This symposium provides an invaluable forum for interdisciplinary exchange at the forefront of drug research.
Lifetime Achievement Awardees
John Schiller, PhD
Deputy Chief, Laboratory of Cellular Oncology
National Cancer Institute
Douglas Lowy, MD
Director
National Cancer Institute
Participants
(more to come as we reconfirm participation for 2021)
Hal Barron, MD
CSO and President of R&D
GlaxoSmithKline
Robert Califf, MD
Head of Strategy and Policy
Verily Life Sciences and Google Health Divisions of Alphabet
Jürgen Eckhardt, MD
Senior Vice President and Head of Leaps by Bayer
Anne Heatherington, PhD
Senior Vice President
Head of Data Sciences Institute
Takeda
Peter Kim, PhD
Virginia and D.K. Ludwig Professor of Biochemistry, Stanford
Roger Kornberg, PhD
Mrs. George A. Winzer Professor in Medicine
Stanford University
Nobel Prize in 2006
Mathai Mammen, MD, PhD
Global Head of Research and Development
Janssen
Lloyd Minor, MD
Carl and Elizabeth Naumann Professorship for the Dean
Stanford School of Medicine
Andrew Plump, MD, PhD
President, Research & Development
Takeda Pharmaceutical Company Limited
Mark Smith, MD, MBA
Founding President & CEO, California Healthcare Foundation
Janet Woodcock, PhD
Acting Commissioner
FDA
Wendy Young, PhD
Senior Vice President, Small Molecule Drug Discovery
Genentech
Michael Basson, PhD
Senior Editor
Nature Medicine
Carmen Chang, MA, JD
General Partner
Head of Asia
New Enterprise Associates
Levi Garraway, MD, PhD
Executive VP, Head of Product Development, and Chief Medical Officer
Genentech/Roche
Mir Imran, MS
Chairman and CEO
Rani Therapeutics
Stephen Knight, MD
President and Managing Partner
F-Prime Capital
Dean Li, MD, PhD
President
Merck Research Laboratories.
Joan Mannick, MD
Co-Founder and Chief Medical Officer
resTORbio
Michael Nedelman
Producer
CNN
Serge Saxonov
Co-Founder and CEO
10x Genomics
Yong Sohn
Corporate President and CSO
Samsung Electronics
Chairman of the Board for Harman
George Yancopoulos, MD, PhD
President and CSO
Regeneron
Elias Zerhouni, MD
Former President for Global R&D, Sanofi
Former Director, NIH
Former US Presidential Science Envoy
Howard Bauchner, MD
Editor in Chief
JAMA and the JAMA Network
Stanley T. Crooke, MD, PhD
Executive Chairman of the Board
Ionis Pharmaceuticals
Helene Gayle, MD, MPH
President and CEO
The Chicago Community Trust
Kathrin Jansen, PhD
Senior Vice President
Head of Vaccine Research and Development
Pfizer
Brian Kobilka, MD
Helene Irwin Fagan Chair in Cardiology
Stanford University
Nobel Prize in 2012
Fady Malik, MD, PhD, FACC, FAHA
Executive Vice President, Research and Development, Cytokinetics
Ken Mills
President and CEO
REGENXBIO
Philip Pizzo, MD
David and Susan Heckerman Professor and Professor of Microbiology and Immunology; Emeritus Dean, Stanford School of Medicine
Marcus Schindler, PhD
Senior Vice President of Global Drug Discovery
Novo Nordisk
Marc Tessier-Lavigne, PhD
President and Bing Presidential Professor
Stanford University
Taiyin Yang, PhD
Executive Vice President, Pharmaceutical Development and Manufacturing, Gilead
Agenda
Organizers
Joseph Wu, MD, PhD
Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine
Sanjay Malhotra, PhD
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
Oregon Health & Science University
Mark Mercola, PhD
Professor of Medicine
Stanford University School of Medicine
Kuldev Singh, MD
Professor of Ophthalmology
Stanford University School of Medicine
Support by
in alphabetical order
Alexandria Ventures
Cytokinetics
